Viewing data from:

IPRATROPIUM BROMIDE

ANDA

IPRATROPIUM BROMIDE | A075693 | THE RITEDOSE CORP

1 strength0 unique patents0 unique exclusivities

API Supply Chain7 active DMFs2 inactive

7 active API suppliers hold Drug Master Files for this ingredient.

OLON SPAIPRATROPIUM BROMIDE

DMF 89731991

LUSOCHIMICA SPAIPRATROPIUM BROMIDE

DMF 89791991

BOEHRINGER INGELHEIM PHARMA GMBH AND CO KGIPRATROPIUM BROMIDE MONOHYDRATE

DMF 142591999

NEULAND LABORATORIES LTDIPRATROPIUM BROMIDE USP

DMF 151302000

AARTI PHARMALABS LTDIPRATROPIUM BROMIDE

DMF 211792007

AMPHASTAR NANJING PHARMACEUTICALS INCIPRATROPIUM BROMIDE USP

DMF 310362017

SCL LIFESCIENCES LTDIPRATROPIUM BROMIDE USP

DMF 379412025

DERIVADOS QUIMICOS SA FINE CHEMICALSInactiveIPRATROPIUM BROMIDE

DMF 231352009

CIPLA LTDInactiveIPRATROPIUM BROMIDE USP

DMF 298432015

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Jan 26, 2001	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — 0.02%

0 patents0 exclusivities▴

SOLUTION;INHALATION | Approved: Jan 26, 2001

No patent or exclusivity listings for this strength.